Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis : A Randomized Controlled Study

Jayne, DavidBlockmans, DanielLuqmani, RaashidMoiseev, SergeyJi, BeulahGreen, YuliaHall, LeanneRoth, DavidHenderson, Robert B.Merkel, Peter A.BREVAS Study Collaborators2020-03-022020-03-022019-06Jayne, D, Blockmans, D, Luqmani, R, Moiseev, S, Ji, B, Green, Y, Hall, L, Roth, D, Henderson, R B, Merkel, P A & BREVAS Study Collaborators 2019, 'Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis : A Randomized Controlled Study', Arthritis and Rheumatology, vol. 71, no. 6, pp. 952-963. https://doi.org/10.1002/art.408022326-5191ORCID: /0000-0002-2001-3998/work/79062801https://hdl.handle.net/2164/13767Funding Information: GlaxoSmithKline12552250engR MedicineImmunology and AllergyRheumatologyImmunologyREfficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis : A Randomized Controlled StudyJournal article10.1002/art.40802http://www.scopus.com/inward/record.url?scp=85064637721&partnerID=8YFLogxK716